ATRICURE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.67 USD | -2.24% |
|
+0.98% | -36.48% |
Presenter SpeechRobert Marcus (Analysts)Good morning, and welcome to the 2022 JPMorgan Healthc...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
22.67
USD
Average target price
47.33
USD
Spread / Average Target
+108.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -36.48% | 109.68Cr | |
| -7.38% | 18TCr | |
| -0.46% | 11TCr | |
| -6.98% | 6.55TCr | |
| +2.65% | 5.07TCr | |
| +5.27% | 4.26TCr | |
| +5.87% | 4.07TCr | |
| +19.92% | 3.11TCr | |
| +16.18% | 2.54TCr | |
| -7.00% | 2.39TCr |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- Transcript : AtriCure, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 07
